Home » Newsletters » BioWorld Science

BioWorld Science

April 12, 2005

View Archived Issues

Oragenics develops manufacturing process for Mutacin 1140

Labedipinedilol A: a potential treatment for atherosclerosis

A novel vasopressin V1b receptor antagonist reduces aggressive behavior

NPY Y2 receptor is involved in PYY3-36-mediated appetite regulation / News in Context

CH-1504 in development at Chelsea Therapeutics for rheumatoid arthritis

Pfizer reviews recent developments

A transdermal testosterone patch improves androgen deficiency in women with POF / News in Context

Avigen discontinues AAV funding to focus on traditional pharmaceuticals

Pfizer to suspend Bextra in Europe, Canada

Phase II trial studies Ceflatonin in combination with Gleevec for CML

Abbott cleared to begin ZOMAXX II trial

Array BioPharma and Genentech expand oncology collaboration

Ligand exercises final option to buy down Ontak royalties

AVE-1330A effective against ceftazidime-resistant Enterobacteriaceae species

New phase I data on the safety and pharmacokinetics of PTC-124

BG-12 reduces symptom scores in moderate-severe psoriasis

AVE-4221 effective against methicillin and multidrug resistant strains of Staphylococcus aureus

XP-13512 shows promise in the treatment of PHN

Emtriva and Truvada set for Japanese launch

Oxypurinol reported to improve ejection fraction of CHF patients

BrachySil enters full development program for pancreatic cancer

Tracleer receives Japanese approval

Novel therapeutic agents for obesity reported by Schering-Plough

Recent patents disclose novel agents for the treatment of infectious diseases

New Japanese approval for Prograf

BLA filing for RotaTeq

Yondelis receives orphan drug designation for ovarian cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...